|Bid||0.00 x 1300|
|Ask||0.00 x 1000|
|Day's range||73.90 - 81.67|
|52-week range||19.57 - 99.27|
|Beta (5Y monthly)||1.65|
|PE ratio (TTM)||43.78|
|Earnings date||08 Feb 2022 - 14 Feb 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||98.50|
Intuitive Surgical (NASDAQ: ISRG) InMode (NASDAQ: INMD) are both technology-intensive companies that are aggressive disruptors in their respective healthcare markets, and the similarities don't end there. Whereas Intuitive Surgical makes da Vinci surgical robots used by general surgeons in hospitals, InMode produces advanced beauty treatment equipment that fills a similar role to both laser skin treatments and plastic surgeries. While Intuitive is a behemoth worth $126 billion, InMode's market cap is only $7 billion -- but both businesses have plenty of room to grow.
Strong fundamentals and big money buy signals make these stocks worthy of extra attention.
Today, we are joined by Moshe Mizrahy, InMode's chairman of the board and CEO, who will start us off with a business update. Then he will turn the call over to Shakil Lakhani, InMode's president of North America to discuss North American operation.